Primo Chemicals (PRIMO)₹21.48−0.46%Commodity Chemicals
In the Jun 2026 quarter (consolidated), Primo Chemicals reported sales of ₹141 Cr, down 1.1% from Jun 2025, and net profit of ₹4.66 Cr, up 14.5% year on year. For the year to Mar 2026, sales were ₹564 Cr and net profit ₹14.95 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 93.54 | 91.75 | 103 | 122 | 135 | 144 | 156 | 142 | 135 | 141 | 145 | 141 |
| Expenses | 97.88 | 88.94 | 102 | 107 | 124 | 126 | 132 | 122 | 120 | 127 | 126 | 120 |
| Operating Profit | −4.34 | 2.80 | 1.44 | 15.12 | 10.61 | 18.66 | 24.00 | 20.41 | 15.31 | 13.59 | 19.03 | 20.82 |
| OPM % | −4.6% | 3.1% | 1.4% | 12.5% | 8.0% | 13.0% | 15.5% | 14.4% | 11.4% | 9.7% | 13.2% | 14.9% |
| Other Income | 4.83 | 3.69 | 5.41 | 5.86 | 5.85 | 4.73 | 4.40 | 5.26 | 4.45 | 4.21 | 5.65 | 5.23 |
| Interest | 4.39 | 5.02 | 5.79 | 5.61 | 5.66 | 5.94 | 5.77 | 5.45 | 4.81 | 4.35 | 3.89 | 3.68 |
| Depreciation | 9.03 | 10.30 | 11.58 | 12.36 | 13.24 | 13.03 | 12.55 | 13.13 | 13.26 | 13.27 | 13.01 | 13.51 |
| Profit before tax | −12.92 | −8.81 | −10.51 | 3.05 | −2.44 | 4.43 | 10.10 | 7.10 | 1.72 | 0.22 | 7.83 | 8.88 |
| Tax % | 5.2% | 74.4% | −164.6% | 485.2% | −645.7% | 56.6% | 111.1% | 56.9% | −61.4% | 261.9% | 34.9% | 58.9% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.36 | 0.00 | 0.00 |
| Net Profit | −12.90 | −15.14 | 7.07 | −11.21 | 12.89 | 2.28 | −0.40 | 4.07 | 4.15 | 1.04 | 6.05 | 4.66 |
| EPS (Rs) | −0.54 | −0.64 | 0.30 | −0.47 | 0.54 | 0.10 | −0.03 | 0.18 | 0.18 | 0.05 | 0.26 | 0.20 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|
| Sales | 224 | 451 | 703 | 393 | 551 | 564 | 562 |
| Expenses | 236 | 363 | 510 | 387 | 483 | 495 | 493 |
| Operating Profit | −12.01 | 87.02 | 192 | 7.01 | 68.04 | 68.02 | 68.75 |
| OPM % | −6.0% | 19.1% | 27.1% | 1.8% | 12.1% | 12.1% | 12.2% |
| Other Income | 54.86 | 14.96 | 25.97 | 18.97 | 20.97 | 19.98 | 19.54 |
| Interest | 5.01 | 9.01 | 8.01 | 18.02 | 22.99 | 18.01 | 16.73 |
| Depreciation | 17.02 | 17.02 | 24.05 | 40.05 | 51.12 | 53.13 | 53.05 |
| Profit before tax | 20.03 | 76.13 | 186 | −31.03 | 15.01 | 17.02 | 18.65 |
| Tax % | 59.0% | 25.0% | 28.0% | −18.0% | 85.0% | 37.0% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | 1.01 | 0.00 | 0.00 | 0.36 |
| Net Profit | 7.97 | 58.83 | 136 | −24.92 | 3.99 | 14.95 | 15.90 |
| EPS (Rs) | 0.54 | 2.45 | 5.68 | −1.06 | 0.16 | 0.64 | 0.69 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Equity Capital | 31.07 | 48.19 | 48.19 | 48.20 | 48.20 | 48.17 |
| Reserves | 65.90 | 228 | 365 | 340 | 343 | 359 |
| Borrowings | 0.99 | 61.02 | 145 | 178 | 169 | 131 |
| Other Liabilities | 149 | 142 | 175 | 150 | 182 | 156 |
| Total Liabilities | 247 | 479 | 733 | 716 | 743 | 694 |
| Fixed Assets | 156 | 155 | 279 | 469 | 498 | 470 |
| CWIP | 35.11 | 178 | 214 | 49.16 | 10.04 | 12.05 |
| Investments | 0.00 | 33.03 | 59.06 | 59.04 | 61.07 | 65.07 |
| Other Assets | 55.15 | 114 | 182 | 139 | 174 | 145 |
| Inventories | 5.98 | 16.97 | 17.95 | 21.93 | 33.89 | 32.92 |
| Trade receivables | 15.95 | 32.87 | 51.79 | 34.87 | 42.88 | 31.88 |
| Cash & equivalents | 7.99 | 24.99 | 30.99 | 0.99 | 7.99 | 3.99 |
| Total Assets | 247 | 479 | 733 | 716 | 743 | 694 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Cash from operating activity | 53.22 | 70.21 | 151 | 14.06 | 64.24 | 65.27 |
| Cash from investing activity | −23.92 | −190 | −232 | −55.79 | −42.80 | −17.93 |
| Cash from financing activity | −33.87 | 136 | 80.71 | 20.91 | −21.93 | −45.86 |
| Net cash flow | −5.02 | 16.06 | −3.01 | −21.08 | 0.00 | 1.01 |
| Capex | 0.65 | 3.79 | 183 | 67.82 | 40.25 | 26.11 |
| Free cash flow | 28.90 | −85.76 | −32.90 | −50.87 | 25.92 | 38.87 |
| CFO / OP % | −421.0% | 96.9% | 95.0% | 397.0% | 94.0% | 97.0% |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Debtor days | 27 | 26 | 27 | 33 | 28 | 21 |
| Inventory days | 51 | 83 | 46 | 105 | 103 | 33 |
| Days payable | 231 | 216 | 112 | 147 | 195 | 34 |
| Cash conversion cycle | −152 | −106 | −38 | −8 | −63 | 20 |
| Working capital days | −159 | −46 | −30 | −88 | −66 | −57 |
| ROCE % | — | 38.9% | 42.9% | −2.0% | 7.0% | 6.0% |
For the Jun 2026 quarter, Primo Chemicals reported sales of ₹141 Cr, down 1.1% year on year and net profit of ₹4.66 Cr, up 14.5% year on year. The operating margin was 14.9%.
Primo Chemicals' sales for the year to Mar 2026 were ₹564 Cr; over the last twelve months they were ₹562 Cr.
Net profit for the year to Mar 2026 was ₹14.95 Cr, and ₹15.90 Cr over the last twelve months. Earnings per share over the same trailing period were ₹0.69.
Primo Chemicals reported borrowings of ₹131 Cr at Mar 2026, against cash and equivalents of ₹3.99 Cr.
Cash from operations was ₹65.27 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹38.87 Cr.